Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

St. Jude Medical Company Profile (NYSE:STJ)

Consensus Ratings for St. Jude Medical (NYSE:STJ) (?)
Ratings Breakdown: 3 Sell Rating(s), 4 Hold Rating(s), 12 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 2.55)
Consensus Price Target: $73.68 (9.75% upside)

Current Analysts' Coverage Summary for St. Jude Medical (NYSE:STJ)
Show:
DateFirmActionRatingPrice TargetDetailsShare
2/24/2015Credit SuisseDowngradeOutperform -> Underperform$74.00ViewTweet This Rating  Share This Rating on StockTwits
2/10/2015Sterne AgeeUpgradeNeutral -> Buy$77.00ViewTweet This Rating  Share This Rating on StockTwits
2/9/2015William BlairReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
2/9/2015Canaccord GenuityReiterated RatingSell$54.00ViewTweet This Rating  Share This Rating on StockTwits
2/9/2015OppenheimerReiterated RatingMarket Perform$70.00ViewTweet This Rating  Share This Rating on StockTwits
1/29/2015BTIG ResearchReiterated RatingBuy$75.00ViewTweet This Rating  Share This Rating on StockTwits
1/29/2015Jefferies GroupBoost Price TargetHold$63.00 -> $69.00ViewTweet This Rating  Share This Rating on StockTwits
1/29/2015CRT CapitalLower Price TargetBuy$80.00 -> $78.00ViewTweet This Rating  Share This Rating on StockTwits
1/23/2015ZacksReiterated RatingNeutral -> Neutral$70.00ViewTweet This Rating  Share This Rating on StockTwits
1/16/2015Needham & Company LLCBoost Price TargetStrong-Buy$78.00 -> $84.00ViewTweet This Rating  Share This Rating on StockTwits
12/29/2014WedbushSet Price TargetBuy$77.00ViewTweet This Rating  Share This Rating on StockTwits
11/21/2014Cowen and CompanyUpgradeMarket Perform -> Outperform$66.00 -> $73.00ViewTweet This Rating  Share This Rating on StockTwits
10/30/2014Stifel NicolausReiterated RatingBuy$66.00 -> $72.00ViewTweet This Rating  Share This Rating on StockTwits
7/17/2014JPMorgan Chase & Co.Reiterated RatingOverweight$74.00 -> $81.00ViewTweet This Rating  Share This Rating on StockTwits
7/17/2014BarclaysReiterated RatingOverweight$75.00 -> $78.00ViewTweet This Rating  Share This Rating on StockTwits
7/17/2014Citigroup Inc.Reiterated RatingSell$53.00 -> $57.00ViewTweet This Rating  Share This Rating on StockTwits
7/17/2014BMO Capital MarketsBoost Price Target$78.00ViewTweet This Rating  Share This Rating on StockTwits
7/14/2014Leerink SwannBoost Price TargetOutperform$75.00 -> $80.00ViewTweet This Rating  Share This Rating on StockTwits
5/29/2014Wells Fargo & Co.Reiterated RatingAverageViewTweet This Rating  Share This Rating on StockTwits
5/9/2014Morgan StanleyReiterated RatingOverweight$75.00ViewTweet This Rating  Share This Rating on StockTwits
4/17/2014Deutsche BankReiterated RatingBuy$78.00ViewTweet This Rating  Share This Rating on StockTwits
2/11/2014Raymond JamesDowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
1/7/2014RBC CapitalUpgradeUnderperform -> Sector Perform$44.00 -> $64.00ViewTweet This Rating  Share This Rating on StockTwits
11/5/2013Sanford C. BernsteinDowngradeOutperform -> Market Perform$64.00 -> $62.00ViewTweet This Rating  Share This Rating on StockTwits
7/19/2013TheStreetReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
5/20/2013Goldman SachsReiterated RatingNeutral$48.00ViewTweet This Rating  Share This Rating on StockTwits
5/16/2013MizuhoBoost Price TargetBuy$48.00 -> $54.00ViewTweet This Rating  Share This Rating on StockTwits
5/13/2013Piper JaffrayReiterated RatingOverweight$46.00ViewTweet This Rating  Share This Rating on StockTwits
4/18/2013Northland SecuritiesBoost Price TargetMarket Perform$42.00 -> $44.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/4/2013 forward)